Today: 16 May 2026
Browse Category

Earnings Reports 9 January 2026 - 10 January 2026

P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

Procter & Gamble will change Kid’s Crest toothpaste packaging after Texas officials said label artwork encouraged unsafe fluoride use by children. The rollout began Jan. 1 and must last five years. P&G shares closed up 0.24% at $141.87, then slipped 0.17% after hours. Investors await the Jan. 22 earnings call for updates on volumes, pricing, and regulatory scrutiny.
10 January 2026
··
Spotify stock dips after broker target cuts — what to watch before SPOT earnings

Spotify stock dips after broker target cuts — what to watch before SPOT earnings

Spotify shares fell 2.6% to $539.37 Friday after Guggenheim and UBS cut their price targets but kept Buy ratings. The company launched a new podcast studio in Los Angeles and projected podcasts will add $10 billion in value over five years. Investors are watching for signs Spotify can grow revenue without losing subscribers. Fourth-quarter results are due Feb. 10.
10 January 2026
··
JPMorgan Chase stock slips after hours as Apple Card switch sharpens focus on next week’s earnings

JPMorgan Chase stock slips after hours as Apple Card switch sharpens focus on next week’s earnings

JPMorgan Chase shares slipped 0.2% to $329.19 in after-hours trading Friday after the bank agreed to take over the Apple Card from Goldman Sachs, booking a $2.2 billion provision for credit losses. The transition is expected to take up to 24 months, pending regulatory approval. JPMorgan will report earnings Tuesday, as investors watch for signs of rising credit costs and trading trends.
10 January 2026
·······
Rocket Lab stock rebounds, holds after-hours bid as RKLB traders weigh insider sales and earnings clock

Rocket Lab stock rebounds, holds after-hours bid as RKLB traders weigh insider sales and earnings clock

Rocket Lab shares closed up 2.1% Friday to $84.85 and edged higher after hours. SEC filings showed CFO Adam Spice and COO Frank Klein sold shares last week under pre-set plans. Investors await fourth-quarter results, expected in late February. The company recently secured an $816 million contract to build missile-warning satellites.
10 January 2026
·····
AMD stock dips after hours as focus shifts from CES to the next catalysts

AMD stock dips after hours as focus shifts from CES to the next catalysts

AMD shares fell 0.7% to $203.17 in after-hours trading Friday, despite the PHLX semiconductor index hitting a record as the S&P 500 closed at an all-time high. The stock moved between $202.88 and $207.27 during the session, with about 24.1 million shares traded. Investors are awaiting AMD’s upcoming results and U.S. inflation data due January 13.
9 January 2026
·····
Palantir stock ticks higher after hours as jobs data cools and Feb. 2 earnings loom

Palantir stock ticks higher after hours as jobs data cools and Feb. 2 earnings loom

Palantir Technologies shares rose 0.3% to $177.49 in after-hours trading Friday, following a regular session with 31.2 million shares traded. The move came as U.S. payrolls rose by 50,000 in December, missing forecasts, while the jobless rate fell to 4.4%. Palantir remains below its 50-day moving average of $180.83 and well under its 52-week high of $207.52. The company’s next earnings report is expected Feb. 2.
9 January 2026
··
Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

Alphabet Class C shares rose about 1% to $329.14 in after-hours trading Friday. CEO Sundar Pichai sold 32,500 Class C shares for roughly $10.4 million on Jan. 7, leaving him with over 2.2 million. The company reports quarterly results Feb. 4. EU regulators are expected to rule by Feb. 10 on Alphabet’s $32 billion Wiz acquisition.
9 January 2026
···
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis Biotherapeutics shares fell 5.3% to $28.29 Friday after an early surge, tracking a shift in rate expectations following a soft U.S. jobs report. Broader biotech indexes rose. Investors are watching for Arcutis’ next earnings on Feb. 24 and an FDA decision on ZORYVE for children by June 29. The Fed’s late-January meeting remains a key focus for traders.
9 January 2026
···
1 … 146 147 148 149 150 … 248

Stock Market Today

  • EagleRock Land (EROK) Stock Price Today and Performance Analysis
    May 16, 2026, 3:41 AM EDT. EagleRock Land (EROK) stock performance data reflects cumulative returns over multiple periods from March 2017 to March 2021. The data covers 1 to 4-year returns, with a disclaimer emphasizing that past performance is not a guarantee of future results. The information is provided by Gotrade Securities Inc., a licensed broker under Labuan Financial Services and Securities Act 2010, highlighting the inherent risks of investment including potential capital loss. This data is general and does not constitute financial advice or an offer to trade. Not intended for U.S. residents or jurisdictions where such distribution is prohibited by law.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop